Skip to main content
. 2019 Feb 4;10(2):99. doi: 10.1038/s41419-019-1371-1

Fig. 1.

Fig. 1

CHD1L overexpression correlates with worse outcome in cisplatin-treated advanced NSCLC patients and expression of CHD1L in NSCLC cell lines. a Immunohistochemistry showing positive nucleus staining in NSCLC patients for CHD1L, weak staining (left, original magnification, ×200); vs. strong staining (right, original magnification, ×200). The boxed regions are magnified and shown in the panel below (original magnification, ×400); scale bar:10 μm. b High CHD1L expression is correlated with poorer disease-free and overall survival rate in NSCLC patients (P<0.001). c The levels of CHD1L protein examined by western blotting in six different lung cancer cell lines